Identification and Mitigation of Defensins in the
Immunopurification of Peptide MHC‑I Antigens from Lung Tissue
Posted on 14.10.2021 - 03:29
The class I major histocompatibility (MHC-I) complex is a set of diverse cell surface receptors encoded by the human leukocyte antigen gene complex. These receptors present intracellular antigens to cytotoxic T cells providing information on the state and health of cells. Changes in the immunopeptidome during cancer may provide novel targets for therapeutic intervention. To understand how the tumor immunopeptidome is altered, we developed a mass spectrometry (MS) based platform for isolating and identifying MHC-I peptide antigens in lung tumors. In the course of our work, we encountered several large unknown peptide contaminants which had not been previously reported. To understand the source of these major contaminants, we isolated them using offline fractionation and identified them by liquid chromatography–tandem mass spectrometry (LC–MS/MS) as members of the host defense protein family known as the defensins. To mitigate their detrimental effects, we modified our “Original” data-dependent acquisition (DDA) MS method to narrowly target the MHC-I peptides based on their physical properties including charge state and molecular weight (“z state” DDA), evaluated field asymmetric ion mobility spectrometry to attempt gas-phase separation prior to MS analysis, and developed an immunodepletion approach using defensin specific antibodies. This modified approach improves peptide identification and reduces the impact of defensin contamination in lung tissue samples.
CITE THIS COLLECTION
Chow, David T.; Rardin, Matthew J. (1753): Identification and Mitigation of Defensins in the Immunopurification of Peptide MHC‑I Antigens from Lung Tissue. ACS Publications. Collection. https://doi.org/10.1021/jasms.1c00024
Select your citation style and then place your mouse over the citation text to select it.
Read the peer-reviewed publication
David T. Chow
Matthew J. Rardin
using offline fractionationphase separation priorlc – mscells providing informationlung tissue samplespeptide mhc ‑lung tissuelung tumorstherapeutic interventionpreviously reportedpeptides basedpeptide antigensnarrowly targetms methodms analysismass spectrometrymajor histocompatibilitymajor contaminantsidentifying mhcdetrimental effectsdependent acquisitiondefensin contaminationbased platformattempt gas